Select Medical Financials

SEM

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 42/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Select Medical has an operating margin of 5.2%, meaning the company retains $5 of operating profit per $100 of revenue. This below-average margin results in a low score of 26/100, suggesting thin profitability after operating expenses. This is down from 5.5% the prior year.

Growth

Select Medical's revenue grew 7.5% year-over-year to $5.2B, a solid pace of expansion. This earns a growth score of 50/100.

Leverage

Select Medical carries a low D/E ratio of 1.01, meaning only $1.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 74/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Select Medical's current ratio of 1.04 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow

Select Medical's free cash flow margin of 5.7% results in a low score of 28/100. Capital expenditures of $222.2M absorb a large share of operating cash flow.

Returns

Select Medical's ROE of 12.7% shows moderate profitability relative to equity, earning a score of 51/100. This is down from 18.9% the prior year.

Altman Z-Score Distress

1.62

Select Medical scores 1.62, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Strong

8/9

Select Medical passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.42x

For every $1 of reported earnings, Select Medical generates $2.42 in operating cash flow ($517.9M OCF vs $214.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.1x

Select Medical earns $2.1 in operating income for every $1 of interest expense ($268.3M vs $128.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

This page shows Select Medical (SEM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$5.2B

YoY+7.5%

5Y CAGR-1.0%

10Y CAGR+5.4%

Select Medical generated $5.2B in revenue in fiscal year 2024. This represents an increase of 7.5% from the prior year.

EBITDA

$472.2M

YoY-0.8%

5Y CAGR-7.2%

10Y CAGR+3.0%

Select Medical's EBITDA was $472.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 0.8% from the prior year.

Free Cash Flow

$295.7M

YoY-16.2%

5Y CAGR+0.5%

10Y CAGR+14.6%

Select Medical generated $295.7M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 16.2% from the prior year.

Net Income

$214.0M

YoY-12.1%

5Y CAGR+7.6%

10Y CAGR+5.9%

Select Medical reported $214.0M in net income in fiscal year 2024. This represents a decrease of 12.1% from the prior year.

EPS (Diluted)

$1.66

YoY-13.1%

5Y CAGR+8.6%

10Y CAGR+6.2%

Select Medical earned $1.66 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 13.1% from the prior year.

Cash & Debt

$59.7M

YoY+13.4%

5Y CAGR-29.2%

10Y CAGR+33.4%

Select Medical held $59.7M in cash against $1.7B in long-term debt as of fiscal year 2024.

Dividends Per Share

$0.50

YoY+0.0%

10Y CAGR+2.3%

Select Medical paid $0.50 per share in dividends in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Shares Outstanding

129M

YoY+0.5%

5Y CAGR-0.8%

10Y CAGR-0.2%

Select Medical had 129M shares outstanding in fiscal year 2024. This represents an increase of 0.5% from the prior year.

Gross Margin

12.2%

YoY+0.4pp

5Y CAGR-2.7pp

Select Medical's gross margin was 12.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the prior year.

Operating Margin

5.2%

YoY-0.4pp

5Y CAGR-3.5pp

10Y CAGR-4.1pp

Select Medical's operating margin was 5.2% in fiscal year 2024, reflecting core business profitability. This is down 0.4 percentage points from the prior year.

Net Margin

4.1%

YoY-0.9pp

5Y CAGR+1.4pp

10Y CAGR+0.2pp

Select Medical's net profit margin was 4.1% in fiscal year 2024, showing the share of revenue converted to profit. This is down 0.9 percentage points from the prior year.

Return on Equity

12.7%

YoY-6.2pp

5Y CAGR-6.5pp

10Y CAGR-3.6pp

Select Medical's ROE was 12.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 6.2 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$37.9M

YoY+197.1%

5Y CAGR-0.3%

10Y CAGR-11.6%

Select Medical spent $37.9M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 197.1% from the prior year.

Capital Expenditures

$222.2M

YoY-3.1%

5Y CAGR+7.2%

10Y CAGR+8.8%

Select Medical invested $222.2M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 3.1% from the prior year.

SEM Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$5.2B+7.5%	$4.8B+4.7%	$4.6B-25.7%	$6.2B+12.2%	$5.5B+1.4%	$5.5B
Cost of Revenue	$4.6B+7.0%	$4.3B+1.1%	$4.2B-20.4%	$5.3B+12.2%	$4.7B+1.5%	$4.6B
Gross Profit	$633.6M+10.9%	$571.6M+42.4%	$401.5M-56.3%	$919.4M+11.9%	$821.3M+1.0%	$812.9M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$225.9M+32.7%	$170.2M+11.2%	$153.0M+4.1%	$147.0M+6.5%	$138.0M+7.5%	$128.5M
Operating Income	$268.3M+0.4%	$267.2M+84.6%	$144.8M-79.7%	$713.8M+25.7%	$567.7M+20.3%	$471.9M
Interest Expense	$128.6M-35.3%	$198.6M+17.5%	$169.1M+24.4%	$136.0M-11.1%	$153.0M-23.7%	$200.6M
Income Tax	$44.8M+53.1%	$29.3M+74.9%	$16.7M-87.1%	$129.8M+16.0%	$111.9M+75.6%	$63.7M
Net Income	$214.0M-12.1%	$243.5M+53.1%	$159.0M-60.5%	$402.2M+55.3%	$259.0M+74.5%	$148.4M
EPS (Diluted)	$1.66-13.1%	$1.91+55.3%	$1.23-58.7%	$2.98+54.4%	$1.93+75.5%	$1.10

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$1.4B+1.8%	$1.3B-1.0%	$1.4B+3.1%	$1.3B+3.2%	$1.3B-0.8%	$1.3B-3.0%	$1.3B+8.5%	$1.2B
Cost of Revenue	$1.2B+2.7%	$1.2B+1.0%	$1.2B-0.2%	$1.2B+3.5%	$1.1B+1.2%	$1.1B+0.1%	$1.1B+4.3%	$1.1B
Gross Profit	$147.4M-5.1%	$155.4M-13.9%	$180.6M+31.4%	$137.5M+1.2%	$135.9M-15.0%	$159.8M-20.3%	$200.5M+39.2%	$144.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$40.0M+12.3%	$35.7M+8.0%	$33.0M-58.8%	$80.2M+69.4%	$47.3M-5.1%	$49.9M+3.0%	$48.4M+9.9%	$44.1M
Operating Income	$73.0M-15.7%	$86.5M-23.3%	$112.7M+434.6%	$21.1M-61.6%	$54.9M-25.7%	$73.9M-37.7%	$118.5M+168.3%	-$173.4M
Interest Expense	$30.0M+0.1%	$30.0M+3.1%	$29.1M+57.4%	$18.5M-41.1%	$31.4M+12.1%	$28.0M-44.9%	$50.8M-0.1%	$50.8M
Income Tax	$11.7M-4.4%	$12.3M-42.7%	$21.5M+578.1%	-$4.5M-202.6%	$4.4M-76.0%	$18.2M-31.7%	$26.7M+164.3%	-$41.5M
Net Income	$28.8M-29.0%	$40.6M-28.4%	$56.7M+453.2%	-$16.1M-128.9%	$55.6M-28.3%	$77.6M-20.0%	$96.9M+109.4%	$46.3M
EPS (Diluted)	$0.23-28.1%	$0.32-27.3%	$0.44+331.6%	$-0.19-144.2%	$0.43-28.3%	$0.60-20.0%	$0.75+525.0%	$0.12

SEM Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$5.6B-27.1%	$7.7B+0.3%	$7.7B+4.1%	$7.4B-3.9%	$7.7B+4.3%	$7.3B
Current Assets	$1.0B-18.9%	$1.3B-1.1%	$1.3B+11.6%	$1.1B-28.5%	$1.6B+31.4%	$1.2B
Cash & Equivalents	$59.7M+13.4%	$52.6M-46.2%	$97.9M+31.8%	$74.3M-87.1%	$577.1M+71.8%	$335.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$821.4M+13.4%	$724.1M-23.1%	$941.3M+5.8%	$889.3M-0.8%	$896.8M+17.6%	$762.7M
Goodwill	$2.3B+2.1%	$2.3B+1.1%	$2.3B-34.5%	$3.4B+2.1%	$3.4B-0.4%	$3.4B
Total Liabilities	$3.6B-41.0%	$6.1B-2.5%	$6.3B+4.7%	$6.0B-0.2%	$6.0B+10.4%	$5.4B
Current Liabilities	$977.7M-21.7%	$1.2B+8.1%	$1.2B-9.3%	$1.3B-11.5%	$1.4B+57.3%	$914.3M
Long-Term Debt	$1.7B-52.8%	$3.6B-6.5%	$3.8B+7.8%	$3.6B+4.9%	$3.4B-1.6%	$3.4B
Total Equity	$1.7B+30.5%	$1.3B+14.8%	$1.1B+1.1%	$1.1B+4.7%	$1.1B+37.6%	$771.0M
Retained Earnings	$770.1M+2.4%	$751.9M+29.4%	$581.0M-2.1%	$593.3M+7.2%	$553.2M+97.7%	$279.8M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$5.7B-1.0%	$5.7B+0.8%	$5.7B+1.6%	$5.6B-29.9%	$8.0B+1.6%	$7.9B+0.2%	$7.9B+2.2%	$7.7B
Current Assets	$1.0B-5.6%	$1.1B-1.0%	$1.1B+7.1%	$1.0B-27.4%	$1.4B+2.9%	$1.4B-5.2%	$1.4B+14.5%	$1.3B
Cash & Equivalents	$60.1M+14.7%	$52.3M-1.6%	$53.2M-10.9%	$59.7M-68.8%	$191.5M+72.2%	$111.2M+20.0%	$92.6M+76.0%	$52.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$825.8M-9.2%	$909.5M+0.1%	$908.2M+10.6%	$821.4M-22.5%	$1.1B-1.7%	$1.1B-5.0%	$1.1B+56.7%	$724.1M
Goodwill	$2.3B+0.1%	$2.3B0.0%	$2.3B0.0%	$2.3B-34.4%	$3.6B+0.8%	$3.5B+0.2%	$3.5B+54.0%	$2.3B
Total Liabilities	$3.7B-2.1%	$3.7B+2.5%	$3.6B+1.1%	$3.6B-36.7%	$5.7B-7.1%	$6.1B-0.9%	$6.2B+1.3%	$6.1B
Current Liabilities	$939.6M+0.1%	$939.0M-0.6%	$944.8M-3.4%	$977.7M-21.5%	$1.2B-0.9%	$1.3B+6.1%	$1.2B-5.1%	$1.2B
Long-Term Debt	$1.7B-5.2%	$1.8B+4.1%	$1.8B+4.5%	$1.7B-45.4%	$3.1B-13.8%	$3.6B-4.4%	$3.8B+4.9%	$3.6B
Total Equity	$1.7B+1.3%	$1.7B-3.0%	$1.7B+2.3%	$1.7B-12.2%	$1.9B+35.2%	$1.4B+3.6%	$1.4B+6.1%	$1.3B
Retained Earnings	$824.8M+2.5%	$804.7M-1.1%	$813.5M+5.6%	$770.1M-27.1%	$1.1B+18.5%	$891.4M+7.3%	$830.8M+10.5%	$751.9M

SEM Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$517.9M-11.0%	$582.1M+104.4%	$284.8M-29.0%	$401.2M-61.0%	$1.0B+130.9%	$445.2M
Capital Expenditures	$222.2M-3.1%	$229.2M+20.4%	$190.4M+5.4%	$180.5M+23.3%	$146.4M-6.8%	$157.1M
Free Cash Flow	$295.7M-16.2%	$352.9M+273.6%	$94.5M-57.2%	$220.7M-75.0%	$881.6M+206.1%	$288.1M
Investing Cash Flow	-$231.0M+14.0%	-$268.5M-18.6%	-$226.3M+11.8%	-$256.6M-122.4%	-$115.4M+63.6%	-$316.7M
Financing Cash Flow	-$311.2M+5.0%	-$327.5M-838.6%	-$34.9M+94.6%	-$647.4M+3.6%	-$671.5M-2182.2%	$32.3M
Dividends Paid	$64.6M+1.1%	$63.9M-1.1%	$64.6M+27.6%	$50.6M	$0	$0
Share Buybacks	$37.9M+197.1%	$12.8M-93.5%	$195.5M+146.0%	$79.5M+395.7%	$16.0M-58.4%	$38.5M

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	$175.3M+58.9%	$110.3M+3290.4%	-$3.5M-102.8%	$125.4M-30.7%	$181.0M-34.9%	$278.2M+517.1%	-$66.7M-137.2%	$179.4M
Capital Expenditures	$53.1M-17.9%	$64.7M+23.6%	$52.3M-17.5%	$63.4M+25.1%	$50.7M-8.8%	$55.5M+5.8%	$52.5M-13.3%	$60.6M
Free Cash Flow	$122.2M+167.9%	$45.6M+181.7%	-$55.8M-190.0%	$62.0M-52.4%	$130.3M-41.5%	$222.6M+286.7%	-$119.2M-200.3%	$118.8M
Investing Cash Flow	-$32.6M+49.6%	-$64.7M-23.6%	-$52.3M+29.5%	-$74.2M-64.5%	-$45.1M+16.6%	-$54.1M+6.2%	-$57.7M+17.1%	-$69.6M
Financing Cash Flow	-$135.0M-190.4%	-$46.5M-194.3%	$49.3M+126.9%	-$183.0M-229.3%	-$55.6M+73.0%	-$205.5M-254.6%	$133.0M+228.7%	-$103.3M
Dividends Paid	$7.7M-1.9%	$7.9M-2.2%	$8.1M-50.0%	$16.1M-0.4%	$16.2M-0.4%	$16.3M+1.3%	$16.0M0.0%	$16.0M
Share Buybacks	$2.0M-97.7%	$86.2M+656.7%	$11.4M-43.0%	$20.0M+20.9%	$16.5M+1080.3%	$1.4M	$0-100.0%	$1.7M

SEM Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	12.2%+0.4pp	11.8%+3.1pp	8.7%-6.1pp	14.8%-0.0pp	14.8%-0.1pp	14.9%
Operating Margin	5.2%-0.4pp	5.5%+2.4pp	3.1%-8.4pp	11.5%+1.2pp	10.3%+1.6pp	8.6%
Net Margin	4.1%-0.9pp	5.1%+1.6pp	3.5%-3.0pp	6.5%+1.8pp	4.7%+2.0pp	2.7%
Return on Equity	12.7%-6.2pp	18.9%+4.7pp	14.2%-22.1pp	36.2%+11.8pp	24.4%+5.2pp	19.3%
Return on Assets	3.8%+0.6pp	3.2%+1.1pp	2.1%-3.4pp	5.5%+2.1pp	3.4%+1.4pp	2.0%
Current Ratio	1.04+0.0	1.01-0.1	1.10+0.2	0.90-0.2	1.11-0.2	1.33
Debt-to-Equity	1.01-1.8	2.78-0.6	3.42+0.2	3.200.0	3.20-1.3	4.47
FCF Margin	5.7%-1.6pp	7.3%+5.3pp	2.1%-1.5pp	3.6%-12.4pp	15.9%+10.7pp	5.3%

Metric	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	10.8%-0.8pp	11.6%-1.7pp	13.3%+2.9pp	10.5%-0.2pp	10.7%-1.8pp	12.5%-2.7pp	15.2%+3.3pp	11.8%
Operating Margin	5.3%-1.1pp	6.5%-1.9pp	8.3%+6.7pp	1.6%-2.7pp	4.3%-1.4pp	5.8%-3.2pp	9.0%+23.2pp	-14.2%
Net Margin	2.1%-0.9pp	3.0%-1.2pp	4.2%+5.4pp	-1.2%-5.6pp	4.4%-1.7pp	6.0%-1.3pp	7.3%+3.5pp	3.8%
Return on Equity	1.7%-0.7pp	2.4%-0.9pp	3.3%	N/A	2.9%-2.6pp	5.5%-1.6pp	7.1%+3.5pp	3.6%
Return on Assets	0.5%-0.2pp	0.7%-0.3pp	1.0%+1.3pp	-0.3%-1.0pp	0.7%-0.3pp	1.0%-0.3pp	1.2%+0.6pp	0.6%
Current Ratio	1.09-0.1	1.150.0	1.16+0.1	1.04-0.1	1.13+0.0	1.09-0.1	1.22+0.2	1.01
Debt-to-Equity	1.03-0.1	1.10+0.1	1.03+0.0	1.01-0.6	1.62-0.9	2.54-0.2	2.75-0.0	2.78
FCF Margin	9.0%+5.6pp	3.4%+7.5pp	-4.1%-8.8pp	4.7%-5.5pp	10.3%-7.1pp	17.4%+26.4pp	-9.0%-18.8pp	9.8%

Similar Companies

PACS Group PACS

$6.1B

Aveanna Healthcare Holdings, Inc. AVAH

$1.6B

Ardent Health ARDT

$1.4B

National Health NHC

$2.6B

P3 HEALTH PARTNERS INC PIII

$6.6M

Frequently Asked Questions

What is Select Medical's annual revenue?

Select Medical (SEM) reported $5.2B in total revenue for fiscal year 2024. This represents a 7.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Select Medical's revenue growing?

Select Medical (SEM) revenue grew by 7.5% year-over-year, from $4.8B to $5.2B in fiscal year 2024.

Is Select Medical profitable?

Yes, Select Medical (SEM) reported a net income of $214.0M in fiscal year 2024, with a net profit margin of 4.1%.

What is Select Medical's earnings per share (EPS)?

Select Medical (SEM) reported diluted earnings per share of $1.66 for fiscal year 2024. This represents a -13.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Select Medical's EBITDA?

Select Medical (SEM) had EBITDA of $472.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Select Medical have?

As of fiscal year 2024, Select Medical (SEM) had $59.7M in cash and equivalents against $1.7B in long-term debt.

What is Select Medical's gross margin?

Select Medical (SEM) had a gross margin of 12.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Select Medical's operating margin?

Select Medical (SEM) had an operating margin of 5.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Select Medical's net profit margin?

Select Medical (SEM) had a net profit margin of 4.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Select Medical pay dividends?

Yes, Select Medical (SEM) paid $0.50 per share in dividends during fiscal year 2024.

What is Select Medical's return on equity (ROE)?

Select Medical (SEM) has a return on equity of 12.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Select Medical's free cash flow?

Select Medical (SEM) generated $295.7M in free cash flow during fiscal year 2024. This represents a -16.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Select Medical's operating cash flow?

Select Medical (SEM) generated $517.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Select Medical's total assets?

Select Medical (SEM) had $5.6B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Select Medical's capital expenditures?

Select Medical (SEM) invested $222.2M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Does Select Medical buy back shares?

Yes, Select Medical (SEM) spent $37.9M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does Select Medical have outstanding?

Select Medical (SEM) had 129M shares outstanding as of fiscal year 2024.

What is Select Medical's current ratio?

Select Medical (SEM) had a current ratio of 1.04 as of fiscal year 2024, which is considered adequate.

What is Select Medical's debt-to-equity ratio?

Select Medical (SEM) had a debt-to-equity ratio of 1.01 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Select Medical's return on assets (ROA)?

Select Medical (SEM) had a return on assets of 3.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Select Medical's Altman Z-Score?

Select Medical (SEM) has an Altman Z-Score of 1.62, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Select Medical's Piotroski F-Score?

Select Medical (SEM) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Select Medical's earnings high quality?

Select Medical (SEM) has an earnings quality ratio of 2.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Select Medical cover its interest payments?

Select Medical (SEM) has an interest coverage ratio of 2.1x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Select Medical?

Select Medical (SEM) scores 42 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.